Production (Stage)
Calidi Biotherapeutics, Inc.
CLDI
$0.315
-$0.005-1.56%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.56M | 9.59M | 1.90M | 836.00K | 1.14M |
| Total Receivables | 50.00K | -- | -- | 181.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 596.00K | 536.00K | 108.00K | 402.00K | 549.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 282.00K | 100.00K | 216.00K | 206.00K | 244.00K |
| Total Current Assets | 11.49M | 10.23M | 2.22M | 1.63M | 1.94M |
|
|
|||||
| Total Current Assets | 11.49M | 10.23M | 2.22M | 1.63M | 1.94M |
| Net Property, Plant & Equipment | 3.43M | 3.80M | 4.22M | 4.58M | 4.96M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 144.00K | 152.00K | 217.00K | 227.00K | 506.00K |
| Total Assets | 15.06M | 14.18M | 6.66M | 6.43M | 7.41M |
|
|
|||||
| Total Accounts Payable | 1.21M | 2.07M | 3.57M | 4.55M | 3.90M |
| Total Accrued Expenses | 1.77M | 2.98M | 3.58M | 4.14M | 5.57M |
| Short-term Debt | -- | 474.00K | 459.00K | 444.00K | 760.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.45M | 3.97M | 3.86M | 3.72M | 4.63M |
| Total Finance Division Other Current Liabilities | -- | -- | 100.00K | 200.00K | 100.00K |
| Total Other Current Liabilities | -- | -- | 100.00K | 200.00K | 100.00K |
| Total Current Liabilities | 5.43M | 9.50M | 11.58M | 13.05M | 14.95M |
|
|
|||||
| Total Current Liabilities | 5.43M | 9.50M | 11.58M | 13.05M | 14.95M |
| Long-Term Debt | 600.00K | 600.00K | 2.37M | 1.93M | 3.38M |
| Short-term Debt | -- | 474.00K | 459.00K | 444.00K | 760.00K |
| Capital Leases | 1.65M | 1.99M | 2.33M | 2.64M | 2.95M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 87.00K | 128.00K | 176.00K | 565.00K | 697.00K |
| Total Liabilities | 7.77M | 12.21M | 16.46M | 18.18M | 21.98M |
|
|
|||||
| Common Stock & APIC | 133.67M | 123.28M | 107.41M | 100.84M | 92.21M |
| Retained Earnings | -126.70M | -121.72M | -117.62M | -112.56M | -106.80M |
| Treasury Stock & Other | -26.00K | -28.00K | -74.00K | -27.00K | 11.00K |
| Total Common Equity | 6.94M | 1.53M | -10.28M | -11.75M | -14.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.94M | 1.53M | -10.28M | -11.75M | -14.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 358.00K | 434.00K | 485.00K | -- | -- |
| Total Equity | 7.30M | 1.97M | -9.80M | -11.75M | -14.57M |
|
|
|||||